BIIB vs BYRN · P/E 21, rev $9.89B vs P/E 18, rev $16.4M
Biogen Inc (BIIB) versus Byrna Technologies Inc (BYRN) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Byrna Technologies Inc (BYRN) is a aerospace & defense company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported BYRN revenue for 2026-05-31 was $16.4M. Net income was -$10.1M. Revenue was down 43.6% from 2026-02-28 to 2026-05-31. BYRN currently screens at market cap $148.6M and trailing P/E 18.2.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. BYRN currently screens at market cap $148.6M and trailing P/E 18.2.
Not investment advice. Open the BIIB and BYRN stock pages for the full models.
Not investment advice.